{"id":"https://openalex.org/W1967722500","doi":"https://doi.org/10.2174/156802611795371350","title":"GABAA Receptor Subtype-Selective Modulators. I. \u03b12/\u03b13-Selective Agonists as Non-Sedating Anxiolytics","display_name":"GABAA Receptor Subtype-Selective Modulators. I. \u03b12/\u03b13-Selective Agonists as Non-Sedating Anxiolytics","alternate_titles":[],"publication_year":2011,"publication_date":"2011-04-18","ids":{"openalex":"https://openalex.org/W1967722500","doi":"https://doi.org/10.2174/156802611795371350","mag":"1967722500","pmid":"https://pubmed.ncbi.nlm.nih.gov/21050172"},"language":"en","primary_location":{"id":"doi:10.2174/156802611795371350","doi":"https://doi.org/10.2174/156802611795371350","is_oa":false,"landing_page_url":"https://doi.org/10.2174/156802611795371350","pdf_url":null,"source":{"id":"https://openalex.org/S107732428","display_name":"Current Topics in Medicinal Chemistry","issn_l":"1568-0266","issn":["1568-0266","1873-4294"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Topics in Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1967722500"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027021273","display_name":"John R. Atack","orcid":"https://orcid.org/0000-0002-3410-791X","observed_orcids":["https://orcid.org/0000-0002-3410-791X"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"John R. Atack","raw_affiliation_strings":["Department of Neuroscience, Janssen Pharmaceutical Research and Development, Beerse, Belgium. JAtack1@its.jnj.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience, Janssen Pharmaceutical Research and Development, Beerse, Belgium. JAtack1@its.jnj.com","institution_ids":["https://openalex.org/I137982388"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5027021273"],"corresponding_institution_ids":["https://openalex.org/I137982388"],"apc_list":null,"apc_paid":null,"fwci":3.3543,"has_fulltext":false,"cited_by_count":146,"citation_normalized_percentile":{"value":0.92842524,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"11","issue":"9","first_page":"1176","last_page":"1202"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gaba-a-receptor","display_name":"GABAA receptor","score":0.8320000171661377},{"id":"https://openalex.org/keywords/subtype-selective-agonists","display_name":"subtype-selective agonists","score":0.7549999952316284},{"id":"https://openalex.org/keywords/alpha1-subunit","display_name":"alpha1 subunit","score":0.7319999933242798},{"id":"https://openalex.org/keywords/benzodiazepine-binding-site","display_name":"benzodiazepine binding site","score":0.7979999780654907},{"id":"https://openalex.org/keywords/triazolopyridazines","display_name":"triazolopyridazines","score":0.9900000095367432},{"id":"https://openalex.org/keywords/imidazopyridines","display_name":"imidazopyridines","score":0.9240000247955322},{"id":"https://openalex.org/keywords/benzimidazole","display_name":"benzimidazole","score":0.7789999842643738},{"id":"https://openalex.org/keywords/benzodiazepine-receptor","display_name":"benzodiazepine receptor","score":0.38499999046325684}],"concepts":[{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.8476877212524414},{"id":"https://openalex.org/C168258287","wikidata":"https://www.wikidata.org/wiki/Q60147","display_name":"GABAA receptor","level":3,"score":0.8248936533927917},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.701772928237915},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6700038313865662},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6521455645561218},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.6388847827911377},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.623216986656189},{"id":"https://openalex.org/C2777602617","wikidata":"https://www.wikidata.org/wiki/Q847705","display_name":"Sedative","level":2,"score":0.5209506750106812},{"id":"https://openalex.org/C2776175493","wikidata":"https://www.wikidata.org/wiki/Q210402","display_name":"Diazepam","level":2,"score":0.5091575980186462},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4963720440864563},{"id":"https://openalex.org/C38533456","wikidata":"https://www.wikidata.org/wiki/Q1671589","display_name":"Intrinsic activity","level":4,"score":0.47872018814086914},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4363689422607422},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.27951955795288086},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21317040920257568},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1860167384147644},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06976976990699768}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D003975","descriptor_name":"Diazepam","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005464","descriptor_name":"Fluorobenzenes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006993","descriptor_name":"Hypnotics and Sedatives","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D006993","descriptor_name":"Hypnotics and Sedatives","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013379","descriptor_name":"Substrate Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D020033","descriptor_name":"Protein Isoforms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058785","descriptor_name":"GABA-A Receptor Agonists","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D058785","descriptor_name":"GABA-A Receptor Agonists","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.2174/156802611795371350","doi":"https://doi.org/10.2174/156802611795371350","is_oa":false,"landing_page_url":"https://doi.org/10.2174/156802611795371350","pdf_url":null,"source":{"id":"https://openalex.org/S107732428","display_name":"Current Topics in Medicinal Chemistry","issn_l":"1568-0266","issn":["1568-0266","1873-4294"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Topics in Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:21050172","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21050172","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current topics in medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:https://orca.cardiff.ac.uk:105892","doi":null,"is_oa":false,"landing_page_url":"https://orca.cardiff.ac.uk/id/eprint/105892/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401195","display_name":"ORCA Online Research @Cardiff (Cardiff University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79510175","host_organization_name":"Cardiff University","host_organization_lineage":["https://openalex.org/I79510175"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.46810001134872437,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2129874579","https://openalex.org/W41628817","https://openalex.org/W2053362224","https://openalex.org/W2016940189","https://openalex.org/W2025429574","https://openalex.org/W1600748339","https://openalex.org/W2151414518","https://openalex.org/W2001619275","https://openalex.org/W1966512228","https://openalex.org/W2033575636"],"abstract_inverted_index":{"The":[0,103,126,306,367],"prototypic":[1],"benzodiazepines,":[2],"such":[3,97,108],"as":[4,60,68,425],"diazepam,":[5],"are":[6,16,41],"not":[7,89,169],"only":[8],"anxiolytic":[9],"but":[10,88],"also":[11,204,304],"produce":[12],"sedation.":[13],"These":[14],"effects":[15,35],"mediated":[17,42],"by":[18,275],"GABA(A)":[19,58,420],"receptors":[20,59,67],"containing":[21],"either":[22,257],"an":[23,173,309],"\u03b11,":[24],"\u03b12,":[25],"\u03b13":[26,152,199,224,293],"or":[27,265],"\u03b15":[28],"subunit":[29],"at":[30,73,119,197,220,233],"which":[31,320,381],"the":[32,61,69,94,120,133,150,198,221,234,245,276,282,285,313,317,335,338,353,360,374,378,383,408,416],"positive":[33],"modulatory":[34],"(i.e.,":[36,237],"agonist":[37,195],"efficacy)":[38],"of":[39,140,256,278,292,301,308,337,352,369,419],"benzodiazepines":[40],"via":[43],"a":[44,138,141,145,191,215,238,248,251,254,289,298,350,370,426],"specific":[45],"benzodiazepine":[46],"recognition":[47],"site.":[48],"Recent":[49],"molecular":[50],"genetic":[51],"and":[52,63,144,166,263,270,281,332,342,356,388,398,412,435],"pharmacological":[53,177,258,402],"data":[54],"point":[55,128],"to":[56,81,123,180,190,213,226,250,348],"\u03b11-containing":[57],"\"sedative\"":[62],"\u03b12-":[64],"and/or":[65,223],"\u03b13-containing":[66],"\"anxiolytic\"":[70],"subtype(s).":[71],"Therefore,":[72],"Merck":[74],"Sharp":[75],"&":[76],"Dohme":[77],"attempts":[78],"were":[79,203,272,405],"made":[80],"identify":[82],"subtype-selective":[83,241],"compounds":[84,98,110,114,187,260,390,404,430],"that":[85,96,157,208,284],"modulate":[86],"\u03b12/\u03b13":[87,121],"\u03b11":[90,124,154,201,227,295],"receptor":[91,421],"function":[92],"with":[93,115,217,230,240,324,431],"prediction":[95],"would":[99],"be":[100,159,211,349],"non-sedating":[101],"anxiolytics.":[102],"initial":[104],"strategy":[105,427],"for":[106,129,172,428],"discovering":[107],"\"anxioselective\"":[109],"focussed":[111],"on":[112],"producing":[113],"much":[116],"higher":[117,194,218],"affinity":[118],"compared":[122,179,225],"subtypes.":[125],"starting":[127],"this":[130,162,167,185,279,329,358],"approach":[131,280],"was":[132,164,168,303,330,346,365],"triazolophthalazine":[134,249],"series":[135,163,186,319,359,414],"developed":[136],"from":[137,247],"combination":[139],"screening":[142],"hit":[143],"literature":[146],"compound":[147,216,239,363],"[1].":[148],"However,":[149,328],"maximum":[151],"versus":[153,200,294],"binding":[155],"selectivity":[156,296],"could":[158],"achieved":[160],"in":[161,175,334,357,433,436],"12-fold":[165],"considered":[170],"sufficient":[171],"appropriate":[174],"vivo":[176,437],"differentiation":[178],"non-selective":[181],"compounds.":[182],"Nevertheless,":[183],"within":[184,407],"demonstrating":[188],"(albeit":[189],"limited":[192],"extent)":[193],"efficacy":[196,219,232,424],"subtype":[202,236,422],"identified.":[205,273,366],"This":[206],"suggested":[207],"it":[209],"might":[210],"possible":[212],"synthesize":[214],"\u03b12":[222],"subtypes,":[228],"ideally":[229],"no":[231,392],"latter":[235],"efficacy).":[242],"By":[243],"changing":[244],"structure":[246],"triazolopyridazine":[252],"core,":[253],"number":[255],"tool":[259,362,403],"(L-838417,":[261],"MRK-067":[262],"MRK-696)":[264],"clinical":[266,384],"development":[267,339],"candidates":[268,340],"(MRK-409":[269],"TPA023)":[271],"Encouraged":[274],"success":[277],"observation":[283],"benzimidazole":[286],"NS-2710":[287],"had":[288,322],"modest":[290],"degree":[291],"efficacy,":[297],"structurally-related":[299],"class":[300],"imidazopyridines":[302],"explored.":[305],"introduction":[307],"additional":[310],"nitrogen":[311,372],"into":[312,373],"imidazopyridine":[314],"core":[315,355,376],"gave":[316],"imidazopyrimidine":[318,354,375,397],"initially":[321],"issues":[323],"poor":[325],"dog":[326],"pharmacokinetics.":[327],"resolved":[331],"resulted":[333],"identification":[336],"MRK-623":[341],"MRK-898.":[343],"A":[344],"fluoroimidazopyridine":[345],"found":[347],"bioisostere":[351],"\u03b13-selective":[361],"TP003":[364],"addition":[368],"further":[371],"produced":[377],"imidazotriazine":[379,399],"series,":[380],"yielded":[382],"candidate":[385],"TPA023B.":[386],"Imidazopyrazinone":[387],"imidazotriazinone":[389],"offered":[391],"advantages":[393],"over":[394],"their":[395],"respective":[396],"analogues.":[400],"Additional":[401],"identified":[406],"pyridine,":[409],"pyrazolotriazine,":[410],"pyridazine":[411],"pyrazolopyridone":[413],"highlighting":[415],"general":[417],"feasibility":[418],"selective":[423],"developing":[429],"novel":[432],"vitro":[434],"profiles.":[438]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1967722500","counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":29},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":13}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
